The first federal trial for people who have developed bladder cancer as a result of taking Actos is scheduled for November of 2014.
The trial is set to start so far in the future in part due to the sheer number of suits, and in part to give attorneys time to choose the best cases to take to trial. Additionally, this allows for more people to file suit against Takeda Pharmaceuticals, the company who manufactured Actos.
Attorneys for both sides of the case will have until June 3, 2013 to choose the cases they will potentially take to trial and reach final decisions by October 16th of that year.
Actos is a Type-2 diabetes medication that has been strongly linked to instances of bladder cancer in people who took it as directed, especially for a year or longer. If you took Actos and have developed bladder cancer, contact the Actos lawsuit attorneys of Williams Kherkher at 800-641-9810.